These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9647528)

  • 1. Friendly IVF: the way of the future?
    Olivennes F; Frydman R
    Hum Reprod; 1998 May; 13(5):1121-4. PubMed ID: 9647528
    [No Abstract]   [Full Text] [Related]  

  • 2. Challenges in ovarian stimulation.
    Merviel P; LE Martelot MT; Roche S; Lelièvre C; Menard M; Auget S; Beauvillard D; Amice V; De Braekeleer M
    Minerva Ginecol; 2016 Dec; 68(6):625-41. PubMed ID: 26930391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined administration of gonadotropin-releasing hormone agonist with human chorionic gonadotropin for final oocyte maturation in GnRH antagonist cycles for in vitro fertilization.
    Kim CH; Ahn JW; You RM; Kim SH; Chae HD; Kang BM
    J Reprod Med; 2014; 59(1-2):63-8. PubMed ID: 24597289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual trigger with gonadotropin-releasing hormone agonist and recombinant human chorionic gonadotropin improves in vitro fertilization outcome in gonadotropin-releasing hormone antagonist cycles.
    Seval MM; Özmen B; Atabekoğlu C; Şükür YE; Şimşir C; Kan Ö; Sönmezer M
    J Obstet Gynaecol Res; 2016 Sep; 42(9):1146-51. PubMed ID: 27199084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the type of gonadotropin-releasing hormone suppression protocol for ovarian hyperstimulation associated with ectopic pregnancy in fresh autologous cycles for in vitro fertilization?
    Londra L; Moreau C; Strobino D; Bhasin A; Zhao Y
    Fertil Steril; 2016 Sep; 106(3):666-72. PubMed ID: 27320035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study.
    Vuong TN; Ho MT; Ha TD; Phung HT; Huynh GB; Humaidan P
    Fertil Steril; 2016 Feb; 105(2):356-63. PubMed ID: 26523330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonist rescue of agonist IVF cycle at risk of OHSS: a case series.
    Martínez F; Mancini F; Solé M; José Gomez M; Beatriz Rodríguez D; Buxaderas R; Rodriguez I; Nolasc Barri P
    Gynecol Endocrinol; 2014 Feb; 30(2):145-8. PubMed ID: 24266696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
    Lin WQ; Yang HY; Lin JJ; Chen X; Ye BL
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropin-releasing hormone antagonist use is associated with increased pregnancy rates in ovulation induction-intrauterine insemination to in vitro fertilization conversions, independent of age and estradiol level on the day of human chorionic gonadotropin administration.
    Quaas AM; Missmer SA; Ginsburg ES
    Fertil Steril; 2010 Feb; 93(2):605-8. PubMed ID: 19324340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is new in IVF?
    Kovacs GT
    Med J Aust; 2014 Sep; 201(5):244-5. PubMed ID: 25163360
    [No Abstract]   [Full Text] [Related]  

  • 12. Dual trigger with gonadotropin-releasing hormone agonist and standard dose human chorionic gonadotropin to improve oocyte maturity rates.
    Griffin D; Feinn R; Engmann L; Nulsen J; Budinetz T; Benadiva C
    Fertil Steril; 2014 Aug; 102(2):405-9. PubMed ID: 24842671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future trend of assisted reproductive technology.
    Chakravarty BN
    J Indian Med Assoc; 1998 Jun; 96(6):169-70, 173. PubMed ID: 9834563
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparison of Alarelin and Triptorelin in the long-protocol ovulation induction in in vitro fertilization and embryo transfer].
    Duan JL; Jiang YH; Liu Y; Zeng QF; Huang YD
    Zhonghua Nan Ke Xue; 2010 Jul; 16(7):611-4. PubMed ID: 20873594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro maturation of oocytes vs in-vitro fertilization with a gonadotropin-releasing hormone antagonist for women with polycystic ovarian syndrome: can superiority be defined?
    Shavit T; Ellenbogen A; Michaeli M; Kartchovsky E; Ruzov O; Shalom-Paz E
    Eur J Obstet Gynecol Reprod Biol; 2014 Aug; 179():46-50. PubMed ID: 24965979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biological assessment criteria during antagonist protocols].
    Plachot M
    J Gynecol Obstet Biol Reprod (Paris); 2004 Oct; 33(6 Pt 2):3S32-5. PubMed ID: 15643685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist or antagonist: what is preferable for in vitro fertilization?
    Ben-Rafael Z
    Gynecol Endocrinol; 2012 Mar; 28 Suppl 1():18-21. PubMed ID: 22394299
    [No Abstract]   [Full Text] [Related]  

  • 18. Scientific evidence shows the need for a fresh approach to IVF.
    Nargund G
    Womens Health (Lond); 2015 Jan; 11(1):11-3. PubMed ID: 25581050
    [No Abstract]   [Full Text] [Related]  

  • 19. The ISMAAR proposal on terminology for ovarian stimulation for IVF.
    Nargund G; Fauser BC; Macklon NS; Ombelet W; Nygren K; Frydman R;
    Hum Reprod; 2007 Nov; 22(11):2801-4. PubMed ID: 17855409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longer ovarian stimulation reduces embryo number and clinical pregnancy rate in long GnRH agonist cycles.
    Dunne C; Lawrence C; Albert A; Havelock JC
    Minerva Ginecol; 2017 Apr; 69(2):135-140. PubMed ID: 27270672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.